Glaxosmithkline Pharmaceuticals Posts 34.7% Surge in Q4 Net Profit

The net profit of Glaxosmithkline pharmaceuticals has been raised to 34.73 percent in the quarter of March 2025. The shares closed at 2721.50 on the May 9th report of the NSE. It has mentioned that given 10.96 percent returns over the last 6 months and 36.12 percent over the last 12 months.

Sales rose by 6.06 percent to Rs. 966.08 crore, and the net profit rose by 34.73 percent to Rs. 260.14 crore by March 2025. During the previous quarter, March 2024, it was Rs. 193.08 crore and sales rose 6.06 percent to Rs. 966.08 crore in the quarter which ended in March 2025 beside Rs. 910.87 by the previous quarter year ended March 2024.

The net profit for the whole year rose by 57.19 percent to Rs. 919.99 crore in the year March 2025 as it rose from Rs. 584.69 crore in the previous year ending March 2024. Sales rose 9.28 percent to Rs. 3723.49 crore in the year ending March 2025 as it earned Rs. 3407.25 crore during the previous year ending March 2024.